Bone Biologics Corporation (BBLGW)

NASDAQ: BBLGW · Real-Time Price · USD · Warrants
20.20
+4.60 (29.49%)
Feb 26, 2025, 5:00 PM EDT - Market closed
17.44%
Market Cap 2.62M
Revenue (ttm) n/a
Net Income (ttm) -7.32M
Shares Out 3.27M
EPS (ttm) -4.83
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Open 21.64
Previous Close 15.60
Day's Range 20.20 - 21.64
52-Week Range 3.00 - 95.04
Beta 0.93
Analysts n/a
Price Target n/a
Earnings Date Feb 21, 2025

About BBLGW

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company’s NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventiona... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 2
Stock Exchange NASDAQ
Ticker Symbol BBLGW
Full Company Profile

Financial Performance

News

There is no news available yet.